Goldman Sachs Analysts Question Whether Curing Patients Is Good for Business
Posted: Fri Apr 13, 2018 10:35 pm
Gizmodo - 4/12/2018 - Kristen V. Brown - Recent advancements in science and medicine have put cures within reach for diseases that have long plagued humankind. In a recent report, though, Goldman Sachs analysts posed an uncomfortable question that quickly sparked criticism. “Is curing patients a sustainable business model?” analysts asked in an April 10 report entitled “The Genome Revolution,” which CNBC first reported. Read more @ https://gizmodo.com/goldman-sachs-analy ... 1825244673